Alejandro Balsa, Petra Díaz Del Campo Fontecha, Lucía Silva Fernández, José Valencia Martín, Virginia Nistal Martínez, Fernando León Vázquez, M Vanesa Hernández Hernández, Héctor Corominas, Rafael Cáliz Cáliz, José María Aguado García, Gloria Candelas Rodríguez, Nora Ibargoyen Roteta, Arturo Martí Carvajal, M Nieves Plana Farras, Janet Puñal Riobóo, Hye Sang Park, Yolanda Triñanes Pego, Virginia Villaverde García
OBJECTIVE: To present recommendations based on the available evidence and the consensus of experts, for risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis. METHODS: Clinical research questions relevant to the purpose of the document were identified. These questions were reformulated in PICO format (patient, intervention, comparison, outcome or outcome) by a panel of experts, selected based on their experience in the area...
December 2023: Reumatología clinica